Proposed Data Collections Submitted for Public Comment and Recommendations, 16368-16369 [E7-6275]
Download as PDF
<![CDATA[
16368
Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices
Maryland 20850,
Gloria.Washington@ahrq.hhs.gov.
Nomination Submissions
Nominations may be submitted in
writing or electronically, but must
include (1) the applicant’s current
curriculum vitae and contact
information, (2) a letter explaining how
this individual meets the qualification
requirements and how he/she would
contribute to the Task Force. The letter
should also attest to the nominee’s
willingness to serve as a member of the
Task Force.
AHRQ will later ask persons under
serious consideration for membership to
provide detailed information that will
permit evaluation of possible significant
conflicts of interest. Such information
will concern matters such as financial
holdings, consultancies, and research
grants or contracts.
Nomination Selection
Nominations for the Task Force will
be selected on the basis of qualifications
as outlined above (see Qualification
Requirements) and the current expertise
needs of the Task Force.
Arrangement for Public Inspection
Nominations and applications are
kept on file at the Center for Primary
Care, Prevention and Clinical
Partnerships, and are available for
review during business hours. AHRQ
does not reply to individual responses,
but considers all nominations in
selecting members. Information
regarded as private and personal, such
as a nominee’s social security number,
home and internet addresses, home
telephone and fax numbers, or names of
family members will not be disclosed to
the public. This is in accord with
agency confidentiality policies and
Department regulations (45 CFR 5.67).
FOR FURTHER INFORMATION CONTACT:
Gloria Washington at
Gloria.Washington@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
jlentini on PROD1PC65 with NOTICES
Background
Under Title IX of the Public Health
Service Act, AHRQ is charged with
enhancing the quality, appropriateness,
and effectiveness of health care services
and access to such services. AHRQ
accomplishes these goals through
scientific research and promotion of
improvements in clinical practice,
including prevention of diseases and
other health conditions, and
improvements in the organization,
financing, and delivery of health care
services (42 U.S.C. 299–299c–7 as
amended by the Healthcare Research
VerDate Aug<31>2005
17:57 Apr 03, 2007
Jkt 211001
and Quality Act of 1999, codified in
scattered sections of 42 U.S.C.
The Task Force is an independent
expert panel, first established in 1984
under the auspices of the U.S. Public
Health Service. Currently, the USPSTF,
under AHRQ’s authorizing legislation
(see in particular, 42 U.S.C. 299b–4(a),
is convened at the call of the Director of
AHRQ. The Task Force is charged with
rigorously evaluating the effectiveness,
cost-effectiveness and appropriateness
of clinical preventive services and
formulating or updating
recommendations for primary care
clinicians regarding the appropriate
provision of preventive services. The
USPSTF transitioned to a standing Task
Force in 2001. Current Task Force
recommendations and associated
evidence reviews are available on the
Internet (https://
www.preventiveservices.ahrq.gov).
Dated: March 27, 2007.
Carolyn M. Clancy,
Director.
[FR Doc. 07–1639 Filed 4–3–07; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–07–06BD]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan Karr, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Economic Analysis of the National
Breast and Cervical Cancer Early
Detection Program—New National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC administers the National Breast
and Cervical Cancer Early Detection
Program (NBCCEDP) that provides
critical breast and cervical cancer
screening services to underserved
women in the United States, the District
of Columbia, 4 U.S. territories, and 13
American Indian/Alaska Native
organizations. The program provides
breast and cervical cancer screening for
eligible women who participate in the
program as well as diagnostic
procedures for women who have
abnormal findings. For the past decade,
the NBCCEDP has provided over 5
million breast and cervical cancer
screening and diagnostic exams to
almost 2.1 million low-income women.
Women diagnosed with cancer through
the program are eligible for Medicaid
coverage through the Breast and
Cervical Cancer Prevention and
Treatment Act passed by Congress in
2000.
The NBCCEDP is the largest organized
cancer screening program in the United
States but to date there has been no
systematic analysis of the economic
costs incurred by the program. CDC is
proposing to collect one year (period
covering 07/01/2005–06/30/2006) of
cost data from all the 68 NBCCEDP
grantees to assess the cost and costeffectiveness of the program. The
information required to perform an
activity-based cost analysis includes:
staff and consultant salaries, screening
costs, contracts and material costs,
provider payments, in-kind
contributions, administrative costs,
allocation of funds and staff time
devoted to specific program activities.
CDC has developed and tested a draft
questionnaire with 9 NBCCEDP grantees
to assess the ability of the grantees to
provide the cost data elements
requested, identify the cost information
required, and to complete the
questionnaire within the allocated
timeframe. The grantees were able to
E:\FR\FM\04APN1.SGM
04APN1
16369
Federal Register / Vol. 72, No. 64 / Wednesday, April 4, 2007 / Notices
complete the questionnaire with the
instructions provided.
The activity-based cost data provided
by the 68 grantees will be used to
evaluate the programs to ensure the
most appropriate use of limited program
resources. Performing an assessment of
the resources expended on NBCCEDP
will provide valuable information to the
CDC and it partners for improving
program efficiency within the various
components of the NBCCEDP including
screening, case management, outreach,
and overall management. The detailed
of the Minimum Data Elements (MDEs),
the additional burden on grantees to
provide the requested cost data will be
modest. If future cost data collection
efforts are undertaken, the response
burden would be further reduced
because the infrastructure established to
capture the data is already in place.
There are no costs to respondents
except their time to participate in the
survey.
cost data will allow CDC to assess the
costs of the various program
components, identify factors that impact
average cost, perform cost-effectiveness
analysis and develop a resource
allocation tool. The collection and
analysis of the cost data will allow CDC
to utilize a more systematic process to
allocate program resources based on
grantees’ past performance, level of
efficiency, and future needs.
Since information on screening and
diagnosis volumes (the effectiveness
measures) are already collected as part
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Number
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form name
Program Director ...............................
Business Manager ............................
Data Manager ...................................
Cost Assessment Tool .....................
...........................................................
...........................................................
68
68
68
1
1
1
4
4
14
272
272
952
Total ...........................................
...........................................................
........................
........................
........................
1,496
Dated: March 28, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–6275 Filed 4–3–07; 8:45 am]
Centers for Disease Control and
Prevention
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
[60Day–07–06AY]
Proposed Project
Proposed Data Collections Submitted
for Public Comment and
Recommendations
Evaluation of the Spanish-Language
Campaign ‘‘Good Morning Arthritis,
Today you will not defeat us.’’—New—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
BILLING CODE 4163–18–P
jlentini on PROD1PC65 with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Joan Karr, CDC
Acting Reports Clearance Officer, 1600
Clifton Road, MS–D74, Atlanta, GA
30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
VerDate Aug<31>2005
17:57 Apr 03, 2007
Jkt 211001
Background and Brief Description
Arthritis affects nearly 43 million
Americans, or about one in every six
people, and is the leading cause of
disability among adults in the United
States. Because of the broad public
health impact of this disease, the
Centers for Disease Control and
Prevention (CDC) developed the
National Arthritis Action Plan in 1998
as a comprehensive approach to
reducing the burden of arthritis in the
United States.
As part of its efforts to implement the
National Arthritis Action Plan, CDC
developed and tested a health
communications campaign promoting
physical activity among Caucasian and
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
African-American adults with arthritis.
In 2003–2004, CDC developed a similar
campaign for Spanish-speaking people
with arthritis. Hispanic populations
have a slightly lower prevalence rate of
self-reported, doctor-diagnosed arthritis,
but Hispanics with arthritis report
greater work limitations, and higher
rates of severe pain than do Caucasian
populations with arthritis.
The Spanish-language campaign,
Good Morning Arthritis, Today you will
not defeat us, is designed to reach
Spanish speaking adults with arthritis
who are aged 45–64, who have high
school education or less, and whose
annual income is less than $35,000. The
key message elements of the Spanish
language health communications
campaign are similar to its English
counterpart, as are the campaign
objectives and materials. The campaign
objectives are to increase target
audience members’ (1) Beliefs about
physical activity as an arthritis
management strategy (there are ‘‘things
they can do’’ to make arthritis better,
and physical activity is an important
part of arthritis management); (2)
Knowledge of the benefits of physical
activity and appropriate physical
activity for people with arthritis; (3)
Confidence in their ability to be
physically active, and (4) Trial of
physical activity behaviors. Based on
formative research, campaign materials
refer to exercise instead of physical
activity. Campaign materials include;
print ads, 30- and 60-second radio ads
and public service announcements, and
desktop displays with brochures for
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 72, Number 64 (Wednesday, April 4, 2007)]
[Notices]
[Pages 16368-16369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-6275]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-06BD]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Joan Karr, CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Economic Analysis of the National Breast and Cervical Cancer Early
Detection Program--New National Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC administers the National Breast and Cervical Cancer Early
Detection Program (NBCCEDP) that provides critical breast and cervical
cancer screening services to underserved women in the United States,
the District of Columbia, 4 U.S. territories, and 13 American Indian/
Alaska Native organizations. The program provides breast and cervical
cancer screening for eligible women who participate in the program as
well as diagnostic procedures for women who have abnormal findings. For
the past decade, the NBCCEDP has provided over 5 million breast and
cervical cancer screening and diagnostic exams to almost 2.1 million
low-income women. Women diagnosed with cancer through the program are
eligible for Medicaid coverage through the Breast and Cervical Cancer
Prevention and Treatment Act passed by Congress in 2000.
The NBCCEDP is the largest organized cancer screening program in
the United States but to date there has been no systematic analysis of
the economic costs incurred by the program. CDC is proposing to collect
one year (period covering 07/01/2005-06/30/2006) of cost data from all
the 68 NBCCEDP grantees to assess the cost and cost-effectiveness of
the program. The information required to perform an activity-based cost
analysis includes: staff and consultant salaries, screening costs,
contracts and material costs, provider payments, in-kind contributions,
administrative costs, allocation of funds and staff time devoted to
specific program activities. CDC has developed and tested a draft
questionnaire with 9 NBCCEDP grantees to assess the ability of the
grantees to provide the cost data elements requested, identify the cost
information required, and to complete the questionnaire within the
allocated timeframe. The grantees were able to
[[Page 16369]]
complete the questionnaire with the instructions provided.
The activity-based cost data provided by the 68 grantees will be
used to evaluate the programs to ensure the most appropriate use of
limited program resources. Performing an assessment of the resources
expended on NBCCEDP will provide valuable information to the CDC and it
partners for improving program efficiency within the various components
of the NBCCEDP including screening, case management, outreach, and
overall management. The detailed cost data will allow CDC to assess the
costs of the various program components, identify factors that impact
average cost, perform cost-effectiveness analysis and develop a
resource allocation tool. The collection and analysis of the cost data
will allow CDC to utilize a more systematic process to allocate program
resources based on grantees' past performance, level of efficiency, and
future needs.
Since information on screening and diagnosis volumes (the
effectiveness measures) are already collected as part of the Minimum
Data Elements (MDEs), the additional burden on grantees to provide the
requested cost data will be modest. If future cost data collection
efforts are undertaken, the response burden would be further reduced
because the infrastructure established to capture the data is already
in place.
There are no costs to respondents except their time to participate
in the survey.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Program Director.............. Cost Assessment 68 1 4 272
Tool.
Business Manager.............. ................ 68 1 4 272
Data Manager.................. ................ 68 1 14 952
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 1,496
----------------------------------------------------------------------------------------------------------------
Dated: March 28, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E7-6275 Filed 4-3-07; 8:45 am]
BILLING CODE 4163-18-P
